Drug intelligence / Profile preview

Familact 2 Plus

Development stage
Phase 4
Lead developer
Zist-Takhmir
Modality
Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Familact 2 Plus is a synbiotic formulation developed by the pharmaceutical company Zist Takhmir. It is an oral capsule containing a concentrated blend of several probiotic bacterial strains combined with a prebiotic fiber, fructooligosaccharides (FOS). The probiotic component typically includes species from the *Lactobacillus*, *Bifidobacterium*, and *Streptococcus* genera, which work synergistically to restore and maintain the balance of the intestinal microbiota. The mechanism of action involves the competitive exclusion of pathogenic microorganisms, the production of antimicrobial substances such as lactic acid and bacteriocins, and the modulation of the host's mucosal immune system. It also aids in strengthening the intestinal epithelial barrier and improving digestive processes. Familact 2 Plus is primarily indicated for the management of functional gastrointestinal disorders like irritable bowel syndrome (IBS), chronic constipation, and various types of diarrhea (including antibiotic-associated and infectious diarrhea), as well as for general immune health support.

Brand names
Familact 2 PlusFamilact2 PlusFamilact-2 PlusFamilact
Other names
Familact synbiotic

Beyond the preview

Go deeper on Familact 2 Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Familact 2 Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call